A detailed history of Ubs Group Ag transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 304,738 shares of SANA stock, worth $770,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
304,738
Previous 240,638 26.64%
Holding current value
$770,987
Previous $1.31 Million 3.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.76 - $6.86 $241,016 - $439,726
64,100 Added 26.64%
304,738 $1.27 Million
Q2 2024

Aug 13, 2024

SELL
$5.23 - $10.44 $696,055 - $1.39 Million
-133,089 Reduced 35.61%
240,638 $1.31 Million
Q1 2024

May 13, 2024

BUY
$4.2 - $11.27 $278,489 - $747,279
66,307 Added 21.57%
373,727 $3.74 Million
Q4 2023

Feb 09, 2024

BUY
$2.8 - $4.55 $557,424 - $905,814
199,080 Added 183.75%
307,420 $1.25 Million
Q3 2023

Nov 09, 2023

SELL
$3.77 - $6.23 $147,218 - $243,281
-39,050 Reduced 26.49%
108,340 $419,000
Q2 2023

Aug 11, 2023

SELL
$3.22 - $7.53 $50,402 - $117,867
-15,653 Reduced 9.6%
147,390 $878,000
Q1 2023

May 12, 2023

SELL
$3.11 - $4.92 $556,164 - $879,848
-178,831 Reduced 52.31%
163,043 $533,000
Q4 2022

Feb 08, 2023

BUY
$3.19 - $6.46 $899,710 - $1.82 Million
282,041 Added 471.38%
341,874 $1.35 Million
Q3 2022

Nov 10, 2022

SELL
$5.58 - $9.04 $932,786 - $1.51 Million
-167,166 Reduced 73.64%
59,833 $359,000
Q2 2022

Aug 10, 2022

SELL
$4.12 - $9.35 $332,945 - $755,592
-80,812 Reduced 26.25%
226,999 $1.46 Million
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $1.03 Million - $3.07 Million
196,844 Added 177.39%
307,811 $2.54 Million
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $849,503 - $1.3 Million
55,962 Added 101.74%
110,967 $1.72 Million
Q3 2021

Nov 15, 2021

BUY
$16.29 - $25.88 $755,318 - $1.2 Million
46,367 Added 536.78%
55,005 $1.24 Million
Q2 2021

Aug 13, 2021

BUY
$16.65 - $32.14 $68,031 - $131,324
4,086 Added 89.76%
8,638 $170,000
Q1 2021

May 12, 2021

BUY
$23.04 - $43.5 $104,878 - $198,012
4,552 New
4,552 $153,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $481M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.